Tilray | TRLY - Assets

Stock Price
9.26
Daily Change
0.11 1.20%
Monthly
-8.13%
Yearly
964.37%
Q2 Forecast
8.92

Tilray reported $2.1B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Canopy Growth CAD 1.11B 36.35M Dec/2025
Cronos Group USD 1.2B 18.73M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Moderna USD 12.34B 203M Dec/2025
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Tilray USD 2.1B 15.95M Sep/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025
Zealand Pharma A/S 15.95B 848.45M Dec/2025